Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $7.0 million.

  • Arcus Biosciences' Non Operating Income fell 4615.38% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year decrease of 2857.14%. This contributed to the annual value of $48.0 million for FY2024, which is 2307.69% up from last year.
  • Per Arcus Biosciences' latest filing, its Non Operating Income stood at $7.0 million for Q3 2025, which was down 4615.38% from $8.0 million recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' Non Operating Income registered a high of $13.0 million during Q2 2024, and its lowest value of $154000.0 during Q1 2021.
  • Its 5-year average for Non Operating Income is $6.7 million, with a median of $8.0 million in 2023.
  • As far as peak fluctuations go, Arcus Biosciences' Non Operating Income plummeted by 7619.78% in 2021, and later skyrocketed by 408848.17% in 2023.
  • Quarter analysis of 5 years shows Arcus Biosciences' Non Operating Income stood at $519000.0 in 2021, then soared by 1248.75% to $7.0 million in 2022, then skyrocketed by 57.14% to $11.0 million in 2023, then decreased by 9.09% to $10.0 million in 2024, then decreased by 30.0% to $7.0 million in 2025.
  • Its Non Operating Income was $7.0 million in Q3 2025, compared to $8.0 million in Q2 2025 and $10.0 million in Q1 2025.